250+ investors that invest in your industry and stage Get
Any industry
Energy
Proptech
Community
Health Care
Gaming
Artificial Intelligence
Climate
Biotech
Impact
Google
EdTech
Venture Capital
Sustainability
Clean Energy
Finance
Retail
Infrastructure
Digital Media
Local
Enterprise Software
Email
Travel
Recruiting
Platforms
Fitness
Wine and Spirits
CleanTech
Mobile Apps
InsurTech
LGBT
Crowdfunding
Oil and Gas
Fashion
Social
Theatre
Sporting Goods
Non Profit
Renewable Energy
Social Impact
Restaurants
Celebrity
Cryptocurrency
Machine Learning
SaaS
Agriculture (AgTech)
Media (Entertainment)
Facebook
Beauty
Blockchain
Publishing
Food and Beverage
Social Network
Web3
Big Data
Organic Food
Video Games
Medical Device
Medical
Wellness
Education
Payments
Art
Social Media
Photography
Music
Franchise
Android
Mobile
Internet
Legal
Construction
eSports
Manufacturing
Sports
Automotive
Hospitality
Financial Services
Mobile Advertising
Cannabis
Biotechnology
FinTech
Consumer
Marketplace
Hardware
Transportation
Real Estate
Life Science
Enterprise
Software
B2B
Film
Any country
Australia
South Korea
Europe
Brazil
Indonesia
Singapore
Saudi Arabia
Africa
Costa Rica
Gibraltar
Oceania
Bahrain
Greece
LATAM
Finland
Algeria
Liberia
Mexico
Lebanon
Asia
Norway
Mauritius
Italy
Middle East
Israel
Taiwan
Tunisia
Nigeria
Zambia
Russian Federation
Tajikistan
Sweden
Zimbabwe
Togo
Puerto Rico
San Marino
Jamaica
Honduras
Isle of Man
Mozambique
Luxembourg
Albania
Pakistan
Kenya
Romania
Bangladesh
Kazakhstan
Cayman Islands
Cambodia
Oman
Cameroon
Colombia
Guatemala
Seychelles
Ireland
China
Japan
Qatar
South Africa
Spain
Sri Lanka
Armenia
Azerbaijan
Austria
Barbados
Argentina
Vietnam
United Arab Emirates
Bulgaria
Belarus
Estonia
Belgium
Bermuda
Bolivia
Egypt
France
Bahamas
Czech Republic
Chile
Denmark
Faroe Islands
Georgia
Ecuador
Belize
Croatia
Dominican Republic
Hong Kong
Switzerland
Ethiopia
Grenada
Ghana
Iraq
Hungary
Iceland
Jersey
Jordan
Kuwait
Liechtenstein
Lithuania
Morocco
Latvia
Mali
Marshall Islands
Myanmar
Malta
Malaysia
Nicaragua
Namibia
Peru
Philippines
Poland
Panama
Portugal
New Zealand
Rwanda
Sierra Leone
Serbia
Slovenia
Senegal
El Salvador
Thailand
Tanzania
Uruguay
Turkey
Ukraine
Cyprus
Uganda
Uzbekistan
Venezuela
India
United States
Germany
Canada
United Kingdom
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Find investors

Top 10 Biotechnology Angel Investors in Denmark (June 2026)

The most active angel investors investing in Denmark Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Denmark Biotechnology startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Per Falholt
Angel
4 Denmark Pre-Seed, Series A, Seed Biotechnology, Robotics, Biopharma $5.9M–$20M
Nicholas Francis
Angel
3 Denmark, United States Seed, Series A SaaS, Robotics, Software $854k–$7.1M
Steen Riisgaard
Angel
2 Denmark Pre-Seed, Series A Biotechnology, Biopharma, Wholesale
Bruce Linton
Angel
2 Canada, United States, Denmark Post-IPO Equity, Seed, Pre-Seed Cannabis, Health Care, Biotechnology $37k–$53M
Giampaolo Cagnin
Angel
2 Italy, Denmark Seed, Pre-Seed Biotechnology, Food and Beverage, Plant-Based Foods $4.2M–$7.8M
Martin Tromp Permin
Angel
1 Denmark Seed Robotics, Biotechnology, Industrial Automation
David Helgason
Angel
1 United States, Denmark, Finland Seed, Series A Software, Gaming, Information Technology $1.1M–$30M
Mads Ingwar
Angel
1 Denmark Seed Robotics, Biotechnology, Industrial Automation
Roland Berger
Angel
1 Germany, Denmark, Switzerland Series A, Series B Financial Services, Information Services, Apps $4.9M–$30M
Peter Sandberg
Angel
1 Denmark, Kenya, Estonia Angel, Pre-Seed, Secondary Market Internet, Mobile Payments, Artificial Intelligence
Access all 12 angel investors in Denmark Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Per Falholt
Angel · Copenhagen, Hovedstaden, Denmark · 4 investments in Denmark Biotechnology startups

A passion and vision for chemistry and biotechnology led Per (born 1958) to Novo A/S, where he started his career as a research chemist. He subsequently held several managerial positions developing products for the detergent industry and rose to Director for Application Technology in the company’s new enzyme development division in 1995.Hemoved to Raleigh, N.C., to head the company’s U.S. application technology unit in 1997, returning to Denmark three years later as Corporate Vice President of the Enzyme Development and Application division. In April 2000, Per merged the Research and Development division into the newly formed Enzyme Business R&D.Per assumed his current position following Novozymes’ demerger from Novo Nordisk in 2000. As chief science officer, he has helped Novozymes develop a unique industrial biotechnology platform which delivers solutions to meet customer needs and support growth.Per holds a M.Sc. in Chemical Engineering from Technical University of Denmark (DTU). Committed to promoting education and research within the sciences, he was appointed Honorary Professor at DTU’s Institute for Systems Biology in 2010 and became Chairman of the Board in 2013. He is also Chairman of the Young Scientists association in Denmark.Per’s current external positions also include Chairman, DTU, board member of DHI Group, board member of ARTs Biologics A/S, and member of the Danish Council for Research Policy.

Show more...

Investment focus

  • Industry: Biotechnology, Robotics, Biopharma
  • Stage:Pre-Seed, Series A, Seed
  • Geography: Denmark

Investor stats

  • Total investments: 5
  • Round size: Series A $5.9M–$20M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
  • Reshape Biotech — Fully digital microbiology developed by Reshape Biotech
  • Synamics Therapeutics — Synamics Therapeutics uses AI and predictive modeling for precision oncology and improved drug discovery. Our adaptive medicine approach helps prolong drug effectiveness and improves outcomes for patients with intractable cancers. Learn more about Synamics Therapeutics and how we leverage AI for personalized, adaptive cancer therapies.
Show all investments...

Nicholas Francis
Angel · Copenhagen, Hovedstaden, Denmark · 3 investments in Denmark Biotechnology startups

Nicholas Francis is Co-founder at framebunker

Show more...

Investment focus

  • Industry: SaaS, Robotics, Software
  • Stage:Seed, Series A
  • Geography: Denmark, United States

Investor stats

  • Total investments: 4
  • Round size: Seed $854k–$7.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Waterplan — Waterplan is a SaaS platform for companies to manage water availability in their facilities.
  • Reshape Biotech — Fully digital microbiology developed by Reshape Biotech
Show all investments...

Steen Riisgaard
Angel · 2 investments in Denmark Biotechnology startups

Steen Riisgaard

Show more...

Investment focus

  • Industry: Biotechnology, Biopharma, Wholesale
  • Stage:Pre-Seed, Series A
  • Geography: Denmark

Investor stats

  • Total investments: 3
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Visibuilt — Visibuilt develops sustainable, bio-based asphalt binders made from mycelium. Replace fossil bitumen with visiBIT.
  • Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
  • Synamics Therapeutics — Synamics Therapeutics uses AI and predictive modeling for precision oncology and improved drug discovery. Our adaptive medicine approach helps prolong drug effectiveness and improves outcomes for patients with intractable cancers. Learn more about Synamics Therapeutics and how we leverage AI for personalized, adaptive cancer therapies.
Show all investments...

Bruce Linton
Angel · Ottawa, Ontario, Canada · 2 investments in Denmark Biotechnology startups

Mr. Linton is the founder of Canopy Growth Corporation (CGC) and co-founder of Tweed Marijuana Inc.Bruce’s primary focus has been to position cannabis brands in a competitive market and to raise the capital necessary to fund such operations. Bruce’s experience as a founder, CEO, and Board member across a wide variety of enterprises has influencedthe positive start of Canopy Growth, which to date has enjoyed market support for capital raises of over $150 million and the distinction of being the first company in the industry to be offered debt instruments by a federal lender. Bruce has led three M&A transactions valued over $500 million total since founding CGC. In addition to his leadership responsibility at Canopy Growth, Bruce is the CEO of communications company Martello Technologies. After beginning his career at Newbridge Networks Corporation, he has since held positions that include General Manager and Re-Founder of Computerland.ca, President and Co-Founder of webHancer Corp, and part of the establishing team at CrossKeys Systems Corporation. He was also part of the leadership team for the NASDAQ/TSX initial public offering at CrossKeys. Bruce has been responsible for the acquisition and/or disposition of over $600 million in business assets, and has established regular engagement with the World Bank and Asia Development Bank while focused on markets in India, Philippines, China, Peru, Colombia, Ecuador, Azerbaijan and Uzbekistan. He is the past Chairman of the Ottawa Community Loan Foundation, past Board Member and Treasurer of Canada World Youth past Board of Governor for Carleton University, past President of the Nepean Skating Club and past President of the Carleton University Students Association.

Show more...

Investment focus

  • Industry: Cannabis, Health Care, Biotechnology
  • Stage:Post-IPO Equity, Seed, Pre-Seed
  • Geography: Canada, United States, Denmark

Investor stats

  • Total investments: 8
  • Round size: Seed $1.8M–$5M; Post-IPO Equity $37k–$53M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Omura — Discover heat-not-burn technology with Omura's dry herb vaporizer devices. Explore sustainable vaping options for hemp & whole flower CBD.
  • MindMed — MindMed discovers, develops, and deploys psychedelic-inspired medicines to improve health, promote wellness, and alleviate suffering. Learn more about our medicines and therapies today.
  • Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
Show all investments...

Giampaolo Cagnin
Angel · 2 investments in Denmark Biotechnology startups

Giampaolo’s aim has always been to apply a disruptive approach to functional food ingredients and that’s how he founded Italiana Ingredienti in ’89 and Campus in ’05. Both companies have been acquired, Italiana Ingredienti by Chr. Hansen in ‘99 and Campus by Firmenich in ’18. Today he serves as Founder and Chairman at Hi-Food, an Italian companyproviding key functional ingredients to food companies, and as a business Angel Investor in several startups.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Plant-Based Foods
  • Stage:Seed, Pre-Seed
  • Geography: Italy, Denmark

Investor stats

  • Total investments: 3
  • Round size: Seed $4.2M–$7.8M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Chromologics — Chromologics produce natural sustainable colors. Our flagship product is ChromoRed which performs better than existing natural, red colorants. ChromoRed is also applicable with vegan, kosher and halal diets.
  • Dreamfarm — We are a team of food-lovers 100% made in Italy! We dreamt of a better, tastier, more sustainable future and decided to join forces to create something special.
Show all investments...

Martin Tromp Permin
Angel · Los Angeles, California, United States · 1 investments in Denmark Biotechnology startups

Martin Permin is a CEO at Pelion in the USA.

Show more...

Investment focus

  • Industry: Robotics, Biotechnology, Industrial Automation
  • Stage:Seed
  • Geography: Denmark

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Reshape Biotech — Fully digital microbiology developed by Reshape Biotech
Show all investments...

David Helgason
Angel · Copenhagen, Hovedstaden, Denmark · 1 investments in Denmark Biotechnology startups

David is a technologist, the founder of Unity Technologies, non-exec director to others, and a restless entrepreneur with a passion for creating feedback loops between innovation and teams and products, applying new and old business models to changing industries, and pushing people to do the very best they can do.David's background is inprogramming, an assortment of university dabbling, creating companies, and helping entrepreneurs. He served as CEO of Unity Technologies since co-founding it in 2003 and until October 2014, with an unflinching vision to democratize game development, and to develop technology and business models for the next phase of the games industry. David Helgason attended the University of Copenhagen.

Show more...

Investment focus

  • Industry: Software, Gaming, Information Technology
  • Stage:Seed, Series A
  • Geography: United States, Denmark, Finland

Investor stats

  • Total investments: 71
  • Round size: Seed $1.1M–$8M; Series A $4.3M–$30M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Yousician — Yousician is a fun way to learn the guitar, piano, bass, ukulele or singing. Enjoy thousands of songs with Yousician as your personal music teacher!
  • Absurd:Joy — absurd:joy is bringing joy to remote collaboration with Tangle
  • Noice — Join the team build an awesome combo of social x playful x platform.
Show all investments...

Mads Ingwar
Angel · Copenhagen, Hovedstaden, Denmark · 1 investments in Denmark Biotechnology startups

Mads Ingwar is the Co-Founder at Invert. He attended DTU - Technical University of Denmark.

Show more...

Investment focus

  • Industry: Robotics, Biotechnology, Industrial Automation
  • Stage:Seed
  • Geography: Denmark

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Reshape Biotech — Fully digital microbiology developed by Reshape Biotech
Show all investments...

Roland Berger
Angel · Munich, Bayern, Germany · 1 investments in Denmark Biotechnology startups

Roland Berger is a Founder of Roland Berger, Munich and has been the Roland Berger GmbH's Honorary Chairman since 2010. Today, Roland Berger has grown to become one of the world's top five strategy consulting firms with 50 offices in 36 countries. The company has a workforce of 2,400 and advises leading international industrial andservice enterprises, as well as public institutions. From the company's foundation in 1967 until 2003, Roland was Chief Executive Officer of the firm, and until 2010 Chairman of the Supervisory Board. Prior to founding his strategy consultancy, Roland was employed as a consultant and ultimately partner at a leading American consulting firm based in Milan and Boston. Roland has been appointed to various expert commissions by several German state governments and the federal government. From 2007 to its dissolution in 2014, Roland was a Member of the High Level Group on Administrative Burdens under the leadership of former Bavarian State Premier Dr. Edmund Stoiber, appointed by the European Commission. Roland is a member of several supervisory boards and advisory councils of national and international companies, foundations and organizations, including Fresenius SE & Co. KGaA (Chairman of the Audit Committee), Bad Homburg; Prime Office REIT-AG, Munich (Chairman of the Supervisory Board); RCS Mediagroup S.p.A.(Vice-President), Milan, Italy. Roland also serves on several international advisory boards, including those of Deutsche Bank AG in Frankfurt, MillerBuckfire in New York and The Blackstone Group in New York. Since 1996 Roland has been a Lecturer and Visiting Professor and since 2000 Honorary Professor for Business Administration and Management Consulting at the Brandenburg Technical University in Cottbus. Furthermore, Roland was appointed a member of the Oxford Martin Commission for Future Generations in 2012. Since 2002, Roland has been on the Business Advisory Council of the State Premier of Saxony-Anhalt and was appointed to the Globalization Council Portugal by the Portuguese President Aníbal Cavaco Silva. Previously, German President Roman Herzog had appointed Roland to the President's Advisory Council for Innovation. Roland has also actively participated in over 20 federal government commissions under Helmut Kohl and Gerhard Schröder. Roland is a member of several supervisory boards and advisory councils of national and international companies, foundations and organizations and invests in many private and listed companies as well as startups. Roland was Honorary Consul General of the Republic of Finland in Bavaria and Thuringia from 1996 to 2015. Roland is Chairman of the Board of Trustees of the Roland Berger Foundation, which he set up personally with an endowment of EUR 50 million. The Roland Berger Foundation is dedicated to the global protection of human dignity and human rights. Each year it confers the Roland Berger Award for Human Dignity. The Foundation also helps gifted children and young people from underprivileged families across Germany and Italy to gain access to the best possible primary and secondary education. Outside work, Roland pursues his interest in modern art and owns a large collection of artworks, mainly by contemporary artists from Europe, the US, South America and China. Roland also loves classical music and supports the Mahler Chamber Orchestra and Bavarian State Opera, among others. Roland loves hiking and cross-country skiing, especially in the Swiss region of Engadin. Roland studied business administration in Munich and Hamburg. (MBA from the Ludwig-Maximilians-Universität, Munich).

Show more...

Investment focus

  • Industry: Financial Services, Information Services, Apps
  • Stage:Series A, Series B
  • Geography: Germany, Denmark, Switzerland

Investor stats

  • Total investments: 7
  • Round size: Series A $4.9M–$30M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Flip — Elevate your employee experience and drive employee engagement, everywhere. Flip unites all HR, comms and operations workflows in one AI-powered employee app.
  • ALOHA — Healthy plant-based foods, snacks & meal replacements. Best organic plant based protein bars, shakes and powders. Nothing artificial. Welcome to ALOHA!
  • Balance Re — Scaling the power of ALM
Show all investments...

Peter Sandberg
Angel · Copenhagen, Hovedstaden, Denmark · 1 investments in Denmark Biotechnology startups

Peter Sandberg is a Co-Founder of Nordic Secondary Fund, and a venture partner at Startup Wise Guys. He has extensive experience as a Business Angel, Asset Management and Wealth Management

Show more...

Investment focus

  • Industry: Internet, Mobile Payments, Artificial Intelligence
  • Stage:Angel, Pre-Seed, Secondary Market
  • Geography: Denmark, Kenya, Estonia

Investor stats

  • Total investments: 17
  • Lead/follow: no public data

Portfolio highlights

  • TRAPMINE — TRAPMINE Endpoint Protection Platform provides fool-proof defense against malware, exploit attempts, file-less malware, ransomware and other forms of targeted attacks.Unlike traditional detection-based approaches like legacy antivirus, TRAPMINE combines proven and innovative technologies such as deep learning, behavior monitoring, endpointdeception and anti-exploit techniques to block cyber threats dead in their tracks. TRAPMINE's easy-deploy and lightweight solution comes with a comfortable built-in security console, at a price/performance ratio unmatchable even by the biggest names in Palo Alto.Why TRAPMINE?Cyber criminals target companies of all sizes from every industry, seeking anything that might be of value. Antivirus and other traditional security solutions are no longer efficient to protect organizations from attacks by today’s modern cyber threat actors. That’s why we founded TRAPMINE. TRAPMINE is created to solve the malware problem for all organizations at a reasonable price.
  • Colibo A/S — Use Colibo's intranet software as your enterprise collaboration platform to increase productivity, drive employee engagement and better internal communications.
  • November First — November First - Betalingsplatform til alle virksomheder
Show all investments...

Biotechnology Angel investor funding in Denmark at a glance

Stats across 13 deals from 12 investors.

12
investors
in Denmark Biotechnology startups
13
deals
in Denmark Biotechnology startups
$6.4M
median round
in Denmark Biotechnology startups
33%
lead investors
lead at least one round
38%
Seed
most common funding stage

Access all 12 angel investors in Denmark Biotechnology startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology Angel Investors in Denmark investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 12 angel investors investing in Denmark Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists